Collectively, these results demonstrate that ADGRG6 exerts potent oncogenic effects in PAAD by promoting cellular proliferation, migration, invasion, and tumor formation, thereby supporting its potential role as a therapeutic target. The gene discussed is ADGRG6; the disease is pancreatic adenocarcinoma.